$781K in expenses

During this first quarter of 2025, the organization returned any pledged funds received from membership fees and educational grants.the organization provides expert guidance and input on pediatric clinical development plans and pediatric clinical trials with the goal of improving the processes and accelerating the development of innovative products for use in children. Additionally, the organization also connects qualified clinical trial sites in our pediatric clinical trial site network with clinical trials for a variety of biopharmaceutical companies.the organization utilizes its network of experts to convene working groups to tackle problems in pediatric clinical development common across a variety of stakeholders, that otherwise would not be addressed in a precompetitive manner.